Related references
Note: Only part of the references are listed.The osteoprotegerin/tumor necrosis factor related apoptosis-inducing ligand axis in the kidney
Riccardo Candido
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis
Zhijuan Diao et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand
Nor Saadah M. Azahri et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Cystatin C: An Emerging Biomarker in Cardiovascular Disease
Christos Angelidis et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
TRAIL-Deficiency Accelerates Vascular Calcification in Atherosclerosis via Modulation of RANKL
Belinda A. Di Bartolo et al.
PLOS ONE (2013)
Mycophenolate Mofetil and Valsartan Inhibit Podocyte Apoptosis in Streptozotocin-Induced Diabetic Rats
Wei Lv et al.
PHARMACOLOGY (2013)
Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate
Xie Qing et al.
CARDIOVASCULAR DIABETOLOGY (2012)
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
S. Jouan-Lanhouet et al.
CELL DEATH AND DIFFERENTIATION (2012)
TNF-related apoptosis-inducing ligand (TRAIL) protects against diabetes and atherosclerosis in Apoe-/- mice
B. A. Di Bartolo et al.
DIABETOLOGIA (2011)
Novel transcript variants of TRAIL show different activities in activation of NF-κB and apoptosis
Pingzhang Wang et al.
LIFE SCIENCES (2011)
Serum osteoprotegerin and tumor necrosis factor related apoptosis inducing-ligand (TRAIL) are elevated in type 2 diabetic patients with albuminuria and serum osteoprotegerin is independently associated with the severity of diabetic nephropathy
Yu-Hung Chang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Cystatin C, a marker for successful aging and glomerular filtration rate, is not influenced by inflammation
Anders Grubb et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2011)
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Vascular Calcification
Maud Chasseraud et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2011)
Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Is a Marker of Kidney Function and Inflammation in Heart and Kidney Transplant Recipients
J. Malyszko et al.
TRANSPLANTATION PROCEEDINGS (2011)
TRAIL Promotes VSMC Proliferation and Neointima Formation in a FGF-2-, Sp1 Phosphorylation-, and NFκB-Dependent Manner
Jeffrey Chan et al.
CIRCULATION RESEARCH (2010)
Association between cystatin C and inflammation in patients with essential hypertension
Takafumi Okura et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2010)
The circulating soluble TRAIL is a negative marker for inflammation inversely associated with the mortality risk in chronic kidney disease patients
Sophie Liabeuf et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice
Qianli Yu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Death receptors and their ligands in atherosclerosis
Mary M. Kavurma et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Expression, regulation and function of trail in atherosclerosis
Mary M. Kavurma et al.
BIOCHEMICAL PHARMACOLOGY (2008)
The death ligand TRAIL in diabetic nephropathy
Corina Lorz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The pathogenesis of diabetic nephropathy
Suma Dronavalli et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
Insulin resistance and postprandial triglyceride levels in primary renal disease
JA Charlesworth et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Emerging non-apoptotic functions of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L
R Di Pietro et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Tissue distribution of the death ligand TRAIL and its receptors
DC Spierings et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2004)
Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes
SE Lamhamedi-Cherradi et al.
DIABETES (2003)
TRAIL-β and TRAIL-γ:: two novel splice variants of the human TNF-related apoptosis-inducing ligand (TRAIL) without apoptotic potential
A Krieg et al.
BRITISH JOURNAL OF CANCER (2003)
Serum cystatin C is superior to serum creatinine as a marker of kidney function: A meta-analysis
VR Dharnidharka et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells:: Role of IFN-α on APO2L/TRAIL expression and -mediated cytotoxicity
G Dorothée et al.
JOURNAL OF IMMUNOLOGY (2002)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: Results from an international comparative study
P Maisonneuve et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2000)
Share Paper
